Recently published study from our laboratory show that pro-tumorigenic cytokine IL6 can enrich for therapy resistant CD133+ population in pancreatic cancer cells.25 Interestingly, we as well as others show that IL6 is the major cytokine produced under obese conditions.26,27. Here, IL6 is linked to pancreatic neoplasm.